920 results on '"Rosti, G."'
Search Results
2. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
3. Salvage high-dose chemotherapy in female patients with relapsed/refractory germ-cell tumors: a retrospective analysis of the European Group for Blood and Marrow Transplantation (EBMT)
4. Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
5. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
6. Differences among young adults, adults and elderly chronic myeloid leukemia patients
7. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry
8. 700P Detection of circulating tumor DNA and chromosome 3p25.3 gain in relapsed/refractory germ cell tumors and impact of salvage high-dose chemotherapy: Results from the Italian Germ Cell Cancer Group 04 study
9. Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database
10. Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working Party
11. The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia
12. Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
13. First-line treatment of chronic myeloid leukemia with nilotinib: critical evaluation
14. Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study
15. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer
16. Differences among young adults, adults and elderly chronic myeloid leukemia patients
17. The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinib
18. Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinib
19. Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib
20. Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry
21. IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis
22. Psychiatric and Psychosocial Concomitants of Abnormal Illness Behaviour in Patients with Cancer
23. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party
24. Multiple cycles of PBPC-supported high-dose carboplatin and paclitaxel following mobilization with epirubicin and cisplatin are feasible but ineffective in treating patients with advanced non-small cell lung cancer
25. A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization
26. Dual tyrosine kinase inhibitors in chronic myeloid leukemia
27. High-dose chemotherapy with autologous haemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)
28. First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors: the experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working Party
29. Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience
30. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients
31. Sexual functions after high-dose chemotherapy in survivors of germ cell tumors
32. Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990–1999
33. High-dose epirubicin, preceded by dexrazoxane, given in combination with paclitaxel plus filgrastim provides an effective mobilizing regimen to support three courses of high-dose dense chemotherapy in patients with high-risk stage II–IIIA breast cancer
34. A phase II study of α-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia
35. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
36. Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors
37. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe
38. High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults
39. RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients
40. Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
41. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-α-based therapy
42. Intensified chemotherapy with stem-cell rescue in germ-cell tumors
43. Peripheral blood progenitor cell (PBPC) mobilization in heavily pretreated patients with germ cell tumors: a report of 34 cases
44. Nilotinib is active in chronic and accelerated phase chronic myeloid leukemia following failure of imatinib and dasatinib therapy
45. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma
46. Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase
47. A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours
48. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience
49. Imatinib therapy for chronic myeloid leukemia patients who relapse after allogeneic stem cell transplantation: a molecular analysis
50. Adjuvant high-dose chemotherapy with autologous haematopoietic stem cell transplantation for breast cancer in Italy: 15-years results from the GITMO registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.